Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Macintyre

Showing results (81-90 of 178) with videos related to

Pageof 18
Sort By:
Clinical Chemistry and Laboratory Medicine|September 17, 2021
Implementation of the new EU IVD regulation - urgent initiatives are needed to avert impending crisisChrista Cobbaert, Ettore D Capoluongo, Florent J L A Vanstapel, et al.
Journal of Cellular and Molecular Medicine|December 21, 2016
Acquired TET2 mutation in one patient with familial platelet disorder with predisposition to AML led to the development of pre-leukaemic clone resulting in T2-ALL and AML-M0Vladimir T Manchev, Hind Bouzid, Iléana Antony-Debré, et al.
Blood|January 23, 2014
SET-NUP214 is a recurrent γδ lineage-specific fusion transcript associated with corticosteroid/chemotherapy resistance in adult T-ALLRaouf Ben Abdelali, Anne Roggy, Thibaut Leguay, et al.
Blood|May 30, 2015
High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphomaMarie-Hélène Delfau-Larue, Wolfram Klapper, Françoise Berger, et al.
Blood Advances|July 5, 2019
Clinical and biological features of PTPN2-deleted adult and pediatric T-cell acute lymphoblastic leukemiaMarion Alcantara, Mathieu Simonin, Ludovic Lhermitte, et al.
Leukemia|July 14, 2020
A transcriptomic continuum of differentiation arrest identifies myeloid interface acute leukemias with poor prognosisJonathan Bond, Aleksandra Krzywon, Ludovic Lhermitte, et al.
Leukemia|June 29, 2018
Polycomb repressive complex 2 haploinsufficiency identifies a high-risk subgroup of pediatric acute myeloid leukemiaJonathan Bond, Elise Labis, Alice Marceau-Renaut, et al.
Gastroenterology|August 28, 2012
Large granular lymphocytic leukemia: a treatable form of refractory celiac diseaseGeorgia Malamut, Bertrand Meresse, Virginie Verkarre, et al.
Science Translational Medicine|May 27, 2021
Epigenetic analysis of patients with T-ALL identifies poor outcomes and a hypomethylating agent-responsive subgroupAurore Touzart, Anand Mayakonda, Charlotte Smith, et al.
Cytometry. Part B, Clinical Cytometry|November 4, 2014
Methodological aspects of minimal residual disease assessment by flow cytometry in acute lymphoblastic leukemia: A French multicenter studyChantal Fossat, Mikael Roussel, Isabelle Arnoux, et al.
Pageof 18

Showing results (81-90 of 178) with videos related to

Sort By:
Pageof 18
Clinical Chemistry and Laboratory Medicine|September 17, 2021
Implementation of the new EU IVD regulation - urgent initiatives are needed to avert impending crisisChrista Cobbaert, Ettore D Capoluongo, Florent J L A Vanstapel, et al.
Journal of Cellular and Molecular Medicine|December 21, 2016
Acquired TET2 mutation in one patient with familial platelet disorder with predisposition to AML led to the development of pre-leukaemic clone resulting in T2-ALL and AML-M0Vladimir T Manchev, Hind Bouzid, Iléana Antony-Debré, et al.
Blood|January 23, 2014
SET-NUP214 is a recurrent γδ lineage-specific fusion transcript associated with corticosteroid/chemotherapy resistance in adult T-ALLRaouf Ben Abdelali, Anne Roggy, Thibaut Leguay, et al.
Blood|May 30, 2015
High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphomaMarie-Hélène Delfau-Larue, Wolfram Klapper, Françoise Berger, et al.
Blood Advances|July 5, 2019
Clinical and biological features of PTPN2-deleted adult and pediatric T-cell acute lymphoblastic leukemiaMarion Alcantara, Mathieu Simonin, Ludovic Lhermitte, et al.
Leukemia|July 14, 2020
A transcriptomic continuum of differentiation arrest identifies myeloid interface acute leukemias with poor prognosisJonathan Bond, Aleksandra Krzywon, Ludovic Lhermitte, et al.
Leukemia|June 29, 2018
Polycomb repressive complex 2 haploinsufficiency identifies a high-risk subgroup of pediatric acute myeloid leukemiaJonathan Bond, Elise Labis, Alice Marceau-Renaut, et al.
Gastroenterology|August 28, 2012
Large granular lymphocytic leukemia: a treatable form of refractory celiac diseaseGeorgia Malamut, Bertrand Meresse, Virginie Verkarre, et al.
Science Translational Medicine|May 27, 2021
Epigenetic analysis of patients with T-ALL identifies poor outcomes and a hypomethylating agent-responsive subgroupAurore Touzart, Anand Mayakonda, Charlotte Smith, et al.
Cytometry. Part B, Clinical Cytometry|November 4, 2014
Methodological aspects of minimal residual disease assessment by flow cytometry in acute lymphoblastic leukemia: A French multicenter studyChantal Fossat, Mikael Roussel, Isabelle Arnoux, et al.
Pageof 18